May 17, 2020

China ventures into drug development with new flu vaccine

pharma
Medicine
Medicine
Admin
2 min
The vaccine is the only the second Chinese vaccine to be considered “safe and effective.”
A new Chinese influenza vaccine has been approved by the World Health Organization, according to The Economic Times. The vaccine is the only the second...

A new Chinese influenza vaccine has been approved by the World Health Organization, according to The Economic Times. The vaccine is the only the second Chinese vaccine to be considered “safe and effective.”

RELATED TOPIC: China's health care IT market to reach $4 billion by 2020

In a statement released by the World Health Organization (WHO), the approval of the vaccine—made by Hualan Biological Bacterin Corp.—involved stringent lab tests and a site inspection.

The other vaccine made in China to achieve WHO pre-qualification was a drug against Japanese encephalitis in 2013.

RELATED TOPIC: This is how women and children receive vaccines in the Congo

“WHO prequalification of the Hualan vaccine is another feather in the cap of China’s growing vaccine manufacturing industry,” said Bernhard Schwartlander, WHO representative in China, in a statement.

He added that the development “shows that the country is set to become one of the preeminent vaccine manufacturers globally.”

According to The Economic Times, “Chinese drug makers saw sales growth speed up and margins widen at the start of the year.”

RELATED TOPIC: TOP 10: Emerging trends in alternative medicine

This is a sign that the world’s second-largest pharmaceuticals market may be “rebounding from a crackdown on corruption and high prices.”

This newly approved vaccine is China’s venture into drug development as the country also approved a new polio vaccine in January of this year—one month after local authorities also approved a home-grown Ebola vaccine. 

Let's connect!   

Read the latest edition of Healthcare Global magazine!

[SOURCE: The Economic Times]

Share article

Jul 16, 2021

Vuram launches automated app to track COVID-19 supplies

COVID19
Automation
supplychain
Technology
2 min
Vuram launches automated app to track COVID-19 supplies
Vuram's Trackable app uses automation to monitor COVID-19 essential supplies in real time

A new app that tracks COVID-19 supplies in real time time has launched. 

Built by hyper-automation services company Vuram, Trackable can monitor the progress of vaccines, oxygen cylinders, PPE, and masks as they move through the supply chain. 

The app's features include street view to facilitate coordination between drivers, and trained facial recognition software powered by Microsoft Azure to ensure goods are only handled by authorised personnel. 

Other functions include: 
 * Demand management for inventories, to prioritise deliveries using automation
 * Demand analysis to predict sales trends based on stock levels
 * Offline multilingual feature for drivers
 * A dashboard to see the status and location of drivers
 * Insights on how products are performing in real-time 

The team at Vuram built Trackable as part of the Appian World 2021 Online Hackathon, where participants can take their ideas for innovative software and create a custom app. The tracking app went on to win the contest. 

“Custom component building is at the heart of this application, and we focussed on making them more creative to provide an improved user experience" said Santosh Kumar, co-developer of Trackable.

"We are happy that we have managed to make it to the top in just a month. On behalf of Vuram, I thank the Appian Hackathon team for their efforts in conducting the event, and my hearty congratulations to all the winners." 

Share article